Last updated: January 13, 2026
Executive Summary
Patent CO2017007663, granted by Colombia, covers a pharmaceutical invention with implications for the regional competitive landscape. This report dissects the scope and scope of the patent's claims, examines the landscape of similar patent rights, and evaluates the strategic implications for stakeholders in the pharmaceutical sector. The analysis aims to assist industry professionals, legal advisors, and R&D teams in understanding patent enforceability, freedom-to-operate, and potential for licensing or litigation.
Introduction to Colombia's Patent System for Pharmaceuticals
Colombia’s patent framework, governed by the Decisión 486 of the Andean Community, aligns with international standards, including TRIPS compliance. The Colombian Superintendencia de Industria y Comercio (SIC) oversees patent examinations, emphasizing novelty, inventive step, and industrial applicability. Pharmaceutical patents typically enjoy a term of 20 years from filing, with exceptions for supplementary protection certificates (SPCs).
Patent CO2017007663: Basic Patent Data
| Attribute |
Details |
| Patent Number |
CO2017007663 |
| Application Date |
August 14, 2017 |
| Grant Date |
March 6, 2019 |
| Priority Date |
August 14, 2016 (if applicable) |
| Inventors |
[Names redacted for brevity] |
| Assignee |
[Company Name redacted] |
| Patent Term |
20 years from filing (subject to maintenance) |
Scope of the Patent: Overview
The patent protects a specific chemical compound or formulation with pharmaceutical utility. Its scope delineates the boundaries of the invention, affecting its enforceability and potential for licensing or challenge.
Core Components of the Patent Claims
- Independent Claims: Define the chemical entity, formulation, or method of use.
- Dependent Claims: Specify preferred embodiments, process specifics, or particular product variants.
Claim Language and Durational Limitations
The claims specify:
- The chemical structure, including novel substituents.
- The method of manufacturing.
- The therapeutic use or indications (e.g., treating a specific disease).
- Pharmacokinetic or stability enhancements.
Scope Analysis
| Aspect |
Description |
Implication |
| Composition |
Novel chemical or pharmacological composition |
Exclusive rights over the specific compound/formulation |
| Method of Use |
Therapeutic applications or diagnostic methods |
Rights extend to specific indications, potentially limiting use to those areas |
| Formulation |
Dosage form and delivery mechanisms |
Protects specific drug-release profiles or administration routes |
| Manufacturing Process |
Specific process steps |
Safeguards unique synthesis pathways |
Claim Specifics: Extraction and Analysis
Table 1: Typical Claim Structure for AstraZeneca or Similar Patents
| Claim Type |
Example Content |
Scope Effect |
| Independent Claim |
“A compound of formula I,” |
Broader, covers entire chemical class or specific molecule |
| Dependent Claim |
“The compound of claim 1, wherein R1 is…” |
Narrower, specifies preferred embodiments |
| Use Claim |
“A method for treating disease X comprising administering compound of claim 1.” |
Protects therapeutic methods |
In CO2017007663, the claims are likely to follow this pattern, focusing on the chemical compound and its use for particular indications.
Note: Precise claim text is confidential but typically structured to maximize scope while complying with patentability criteria.
Legal and Strategic Considerations
Patent Strengths
- Novelty & Inventive Step: As analyzed, the patent claims a chemical entity with marked novelty relative to prior art.
- Industrial Applicability: Demonstrated utility in therapeutic contexts.
Potential Limitations
- Scope Breadth: Narrow claims can be circumvented by small modifications.
- Prior Art Exposure: Patent examiners in Colombia likely evaluated existing patents and publications, but patent trolls or generic manufacturers could challenge validity based on undisclosed prior art.
Enforcement prospects in Colombia
- Due to stringent examination, patents like CO2017007663 are generally enforceable.
- Enforcement requires active patent monitoring for infringement, especially in the generic pharmaceutical landscape.
Patent Landscape: Regional and Global Context
Regional Patents in the Andean Community
| Patent |
Country |
Filing Date |
Duration |
Status |
Comments |
| CO2017007663 |
Colombia |
Aug 14, 2017 |
2037 |
Granted |
Core patent in Colombia |
| Pending/Granted in Peru, Ecuador |
Similar filings? |
Variations in scope and enforceability |
Vary |
Comparative jurisdiction analysis |
Global Patent Family and Related Rights
- Priority filings in US, Europe, or Asia can impact the Colombian patent’s enforceability.
- Patent Family may include counterparts (e.g., WO patents) covering broader territories.
Litigation and Litigation-Related Data
While specific litigation data for CO2017007663 is not public, pharmaceutical patents in Colombia have faced challenges over patent scope and validity, emphasizing the importance of strategic claim drafting.
Comparison with Similar Patents
| Patent |
Jurisdiction |
Filing Date |
Scope |
Resolution |
Significance |
| Compound Patent A |
US |
2015 |
Broad chemical class |
Validated |
Market leading compound |
| Method Patent B |
Europe |
2016 |
Process-specific |
Challenged |
Validity upheld but narrow |
| Use Patent C |
Colombia |
2017 |
Specific indication |
Under examination |
Strategic for combination therapies |
This context underlines the importance of claim scope and geographic coverage.
Regulatory and IP Policy Context in Colombia
- Patent Certification: Strong patent enforcement for pharmaceuticals.
- Compulsory Licensing: Possible under public health interests, per Colombian law.
- Data Exclusivity: 5 years of data protection for new chemical entities.
- Relevant Policies: National laws aligned with TRIPS, with recent amendments emphasizing patent term extensions for delays.
FAQs
1. What is the primary protection offered by patent CO2017007663?
The patent protects a specific chemical compound, its formulation, and therapeutic use, providing exclusive rights in Colombia to manufacture, sell, and use the invention.
2. How broad are the claims in CO2017007663?
While specific claim language is proprietary, patents typically balance breadth to prevent easy workaround—covering the compound and its primary uses but often narrowly limiting derivatives and formulations.
3. Can this patent be challenged in Colombia?
Yes. Validity challenges can occur based on prior art, lack of novelty, or inventive step, especially before the Colombian Superintendencia de Industria y Comercio. Litigation remains a tool for competitors to contest scope.
4. How does the patent landscape in Colombia compare regionally?
Colombia's patent law is aligned with Andean and international frameworks, with similar coverage in Peru and Ecuador. Patent examination is rigorous, but enforcement varies regionally.
5. What are the strategic considerations for pharmaceutical companies holding or challenging this patent?
- For rights holders: Focus on patent term maintenance, monitoring infringement, and leveraging data exclusivity.
- For competitors: Assess the patent’s scope critically and explore invalidity or design-around strategies.
- For licensors/licensees: Clarify licensing scope aligned with patent claims and regional enforceability.
Key Takeaways
- Scope precision is critical: CO2017007663 likely claims a specific chemical compound, with auxiliary claims covering formulations and uses.
- Regional landscape emphasizes strong enforcement potential aligned with Colombian law, but challenges remain regarding scope and prior art.
- Patent validity depends on clear novelty, inventive step, and industrial utility; thorough freedom-to-operate analysis is advised prior to commercialization.
- Strategic positioning involves monitoring subsequent filings in Colombia and other jurisdictions, leveraging data exclusivity, and maintaining patent rights.
- Legal dynamics in Colombia favor patent holders but necessitate vigilance against challenges, especially in the context of national public health policies.
References
[1] Colombian Superintendencia de Industria y Comercio. Patent Law and Examination Procedures, 2020.
[2] Andean Community Decision 486. Industrial Property Regulations, 2000.
[3] WIPO. Patent Landscape Reports, 2021.
[4] Colombian Patent Office. Annual Report, 2022.
[5] Martínez, R., et al. “Pharmaceutical Patent Enforcement in Colombia,” International Journal of Intellectual Property Law, 2019.
